This notice is a combined synopsis/solicitation for commercial items prepared in accordance with the format in Federal Acquisition Regulation (FAR) Subpart 12.6 "Streamlined Procedures for Evaluation and Solicitation for Commercial Items," as applicable, and as supplemented with additional information included in this notice. This announcement constitutes the only solicitation; quotes are being requested and a written solicitation document will not be issued. Submit offers on RFQ-RML-D-1806021.

This solicitation is a request for quotes (RFQ).The solicitation documents and incorporated provisions and clauses are those in effect through Federal Acquisition Circular 2005-89 July 14th ,2016.
The associated North American Industry Classification System (NAICS) code for this procurement is 334516 with a small business size standard of 1000.
This is not a total small business set aside.

The National Institute of Allergy and infectious Diseases (NIAID) is looking to acquire an X-Clarity Electrophoretic Tissue Clearing System. This is required for advanced clarity of tissue samples as opposed to current methods. It is imperative the instrument is able to maintain sample integrity in addition to achieving the most advanced clarity possible. Additional concerns are maintaining a benchtop setting with the least possible noise possible. Must be an authorized reseller of X-Clarity products prior to award. List of requested products below.
Catalog # C10001 1 EACH X-Clarity Tissue Clearing System w/ starter kit breakdown of individual items are as follows.
Catalog # C10101 1 EACH X-Clarity ETC Chamber
Catalog # C10201 1 EACH X-Clarity ETC Controller
Catalog # C10301 1 EACH X-Clarity Pump
Catalog # C10401 1 EACH X-Clarity Reservoir
Catalog # C12001 5 EACH Tissue Container (20 units)
Catalog # C12002 1 EACH Container Holder for 1 Tissue Container
Catalog # C12101 1 EACH Multi-Cable
Catalog # C12102 1 EACH X-Clarity Reservoir Cap w/ Temp Probe
Catalog # C12103 1 EACH Snap-Lock Connector Tube
Catalog # C12104 1 EACH Peristaltic Pump Tube
Catalog # C13001 1 EACH Electrophoretic Tissue Clearing Solution

Applicable shipping and warranty information must be quoted. Must be a certified reseller of this requirement.

FOB Point shall be Destination; Bethesda, MD 20892).

Place of Performance:
(NIH/NIAID
Bethesda, MD 20892)
United States

Award will be based on the capability of the item offered to meet the above stated salient characteristics, price, past performance, delivery, warranty, and the best value to the government.

The following FAR provisions apply to this acquisition:
52.212-1 Instructions to Offerors Commercial Items (Oct 2015)
FAR 52.212-3 Offerors Representations and Certifications - Commercial Items (April 2016)
Offerors must complete annual representations and certifications on-line at http://www.sam.gov in accordance with FAR 52.212-3 Offerors Representations and Certifications- Commercial Items
The following contract clauses apply to this acquisition:
FAR 52-212-4 Contract Terms and Conditions Commercial Items (May 2015)
FAR 52-212.5 Contract Terms and Conditions Required to Implement Statutes or Executive Orders Commercial Items (Mar 2016)
FAR 52.209-2 Prohibition on Contracting with Inverted Domestic Corporations-Representation (Nov 2015)

The applicable subparagraphs of FAR52.212-5 are included in the attachment to this posting.

By submission of an offer, the offeror acknowledges the requirement that a prospective awardee shall be registered in the System for Award Management (SAM) database prior to award, during performance, and through final payment of any contract, basic agreement, basic ordering agreement, or blanket purchasing agreement resulting from this solicitation (www.sam.gov).

Copies of the above-referenced provisions and clauses are available from http://www.acquisition.gov/far/loadmainre.html or, upon request, either by telephone or fax.

This is an open-market combined synopsis/solicitation for an X-Clarity Tissue Clearing System as defined herein. The government intends to award a purchase order as a result of this combined synopsis/solicitation that will include the terms and conditions set forth herein. To facilitate the award process all quotes should include a statement regarding the terms and conditions herein as follows:
"The Terms and conditions in the solicitation are acceptable to be included in the award document without modification, deletion or addition."
OR
"The terms and conditions in the solicitation are acceptable to be included in the award document with the exception, deletion, or addition of the following:"
(Quoter shall list exception(s) and rationale for the exception(s).)
Submission shall be received not later than August 8th, 2016 at 4:00PM MST.

Offers may be mailed, e-mailed or faxed to (Michael Barrett); (Fax - 406-363-9288), [email protected] Late submissions shall be treated in accordance with the solicitation provision at FAR 52.212-1(f)

All responsible sources may submit an offer that will be considered by this Agency.
Any questions or concerns regarding this solicitation should be forwarded in writing via e-mail to MICHAEL BARRETT at [email protected].

Bid Protests Not Available